Literature DB >> 10508051

Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha.

J Theys1, S Nuyts, W Landuyt, L Van Mellaert, C Dillen, M Böhringer, P Dürre, P Lambin, J Anné.   

Abstract

Recombinant plasmids were constructed to secrete mouse tumor necrosis factor alpha (mTNF-alpha) from Clostridium acetobutylicum. The shuttle plasmids contained the clostridial endo-beta1, 4-glucanase (eglA) promoter and signal sequence that was fused in frame to the mTNF-alpha cDNA. The construction was first tested in Escherichia coli and then introduced in C. acetobutylicum DSM792 by electroporation. Controls confirmed the presence and stability of the recombinant plasmids in this organism. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and an in vitro cytotoxic assay were used to monitor expression and secretion of mTNF-alpha during growth. Significant levels of biologically active mTNF-alpha were measured in both lysates and supernatants. The present report deals with investigations on the elaboration of a gene transfer system for cancer treatment using anaerobic bacteria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508051      PMCID: PMC91569          DOI: 10.1128/AEM.65.10.4295-4300.1999

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  34 in total

1.  Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours.

Authors:  P Lambin; J Theys; W Landuyt; P Rijken; A van der Kogel; E van der Schueren; R Hodgkiss; J Fowler; S Nuyts; E de Bruijn; L Van Mellaert; J Anné
Journal:  Anaerobe       Date:  1998-08       Impact factor: 3.331

2.  Microbial colonization of tumors in relation to the upper gastrointestinal tract in patients with gastric carcinoma.

Authors:  S Sjöstedt; L Kager; A Heimdahl; C E Nord
Journal:  Ann Surg       Date:  1988-03       Impact factor: 12.969

3.  Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity.

Authors:  M N Teng; B H Park; H K Koeppen; K J Tracey; B M Fendly; H Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment.

Authors:  M J Lemmon; P van Zijl; M E Fox; M L Mauchline; A J Giaccia; N P Minton; J M Brown
Journal:  Gene Ther       Date:  1997-08       Impact factor: 5.250

Review 5.  Tumor necrosis factor activities and cancer therapy--a perspective.

Authors:  R S Sidhu; A P Bollon
Journal:  Pharmacol Ther       Date:  1993-01       Impact factor: 12.310

6.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

Authors:  S M Laster; J G Wood; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

7.  A set of synthetic oligodeoxyribonucleotide primers for DNA sequencing in the plasmid vector pBR322.

Authors:  R B Wallace; M J Johnson; S V Suggs; K Miyoshi; R Bhatt; K Itakura
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

Review 8.  Chemotherapeutic tumour targeting using clostridial spores.

Authors:  N P Minton; M L Mauchline; M J Lemmon; J K Brehm; M Fox; N P Michael; A Giaccia; J M Brown
Journal:  FEMS Microbiol Rev       Date:  1995-10       Impact factor: 16.408

9.  Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.

Authors:  A Asher; J J Mulé; C M Reichert; E Shiloni; S A Rosenberg
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

10.  Structure of an endo-beta-1,4-glucanase gene from Clostridium acetobutylicum P262 showing homology with endoglucanase genes from Bacillus spp.

Authors:  H Zappe; W A Jones; D T Jones; D R Woods
Journal:  Appl Environ Microbiol       Date:  1988-05       Impact factor: 4.792

View more
  16 in total

Review 1.  Tumour-targeting bacteria engineered to fight cancer.

Authors:  Shibin Zhou; Claudia Gravekamp; David Bermudes; Ke Liu
Journal:  Nat Rev Cancer       Date:  2018-12       Impact factor: 60.716

2.  Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters.

Authors:  S Nuyts; L Van Mellaert; S Barbé; E Lammertyn; J Theys; W Landuyt; E Bosmans; P Lambin; J Anné
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

3.  Clostridium beijerinckii cells expressing Neocallimastix patriciarum glycoside hydrolases show enhanced lichenan utilization and solvent production.

Authors:  A M López-Contreras; H Smidt; J van der Oost; P A Claassen; H Mooibroek; W M de Vos
Journal:  Appl Environ Microbiol       Date:  2001-11       Impact factor: 4.792

4.  Improvement of cellulolytic properties of Clostridium cellulolyticum by metabolic engineering.

Authors:  Emmanuel Guedon; Mickaël Desvaux; Henri Petitdemange
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

Review 5.  Engineering the perfect (bacterial) cancer therapy.

Authors:  Neil S Forbes
Journal:  Nat Rev Cancer       Date:  2010-10-14       Impact factor: 60.716

6.  Clostridial spores for cancer therapy: targeting solid tumour microenvironment.

Authors:  Brittany Umer; David Good; Jozef Anné; Wei Duan; Ming Q Wei
Journal:  J Toxicol       Date:  2012-06-07

7.  Tumor-targeting bacterial therapy: A potential treatment for oral cancer (Review).

Authors:  Sai Liu; Xiaoping Xu; Xin Zeng; Longjiang Li; Qianming Chen; Jing Li
Journal:  Oncol Lett       Date:  2014-09-11       Impact factor: 2.967

8.  Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β.

Authors:  Jung-Eun Kim; Thuy Xuan Phan; Vu Hong Nguyen; Hong-Van Dinh-Vu; Jin Hai Zheng; Misun Yun; Sung-Gyoo Park; Yeongjin Hong; Hyon E Choy; Michael Szardenings; Won Hwang; Jin-A Park; SunHee Park; Sin-Hyeog Im; Jung-Joon Min
Journal:  Theranostics       Date:  2015-10-06       Impact factor: 11.556

9.  Intratumoural production of TNFα by bacteria mediates cancer therapy.

Authors:  Carola Murphy; Elizabeth Rettedal; Panos Lehouritis; Ciarán Devoy; Mark Tangney
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

10.  Engineering Salmonella as intracellular factory for effective killing of tumour cells.

Authors:  Eva María Camacho; Beatriz Mesa-Pereira; Carlos Medina; Amando Flores; Eduardo Santero
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.